Treace Medical Concepts, Inc. (TMCI)
TMCI Stock Price Chart
Explore Treace Medical Concepts, Inc. interactive price chart. Choose custom timeframes to analyze TMCI price movements and trends.
TMCI Company Profile
Discover essential business fundamentals and corporate details for Treace Medical Concepts, Inc. (TMCI) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
23 Apr 2021
Employees
477.00
Website
https://www.treace.comCEO
John T. Treace
Description
Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement. The company also provides Lapiplasty Mini-Incision precision system. In addition, it offers products to address ancillary surgical procedures, including akin osteotomies, weil osteotomies, intercuneiform stabilization, lesser tarsometatarsal joint fusions, and autograft bone harvesting, as well as for MTP fusion. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra Beach, Florida.
TMCI Financial Timeline
Browse a chronological timeline of Treace Medical Concepts, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 May 2026
Upcoming earnings on 25 Feb 2026
Upcoming earnings on 4 Nov 2025
EPS estimate is -$0.28, while revenue estimate is $49.60M.
Earnings released on 7 Aug 2025
EPS came in at -$0.28 surpassing the estimated -$0.29 by +3.45%, while revenue for the quarter reached $47.39M , missing expectations by -4.95%.
Earnings released on 8 May 2025
EPS came in at -$0.25 surpassing the estimated -$0.31 by +19.35%, while revenue for the quarter reached $52.57M , beating expectations by +6.16%.
Earnings released on 27 Feb 2025
EPS came in at -$0.01 surpassing the estimated -$0.04 by +75.00%, while revenue for the quarter reached $68.71M , beating expectations by +2.26%.
Earnings released on 5 Nov 2024
EPS came in at -$0.25 surpassing the estimated -$0.27 by +7.41%, while revenue for the quarter reached $45.09M , missing expectations by -32.65%.
Earnings released on 6 Aug 2024
EPS came in at -$0.34 falling short of the estimated -$0.29 by -17.24%, while revenue for the quarter reached $44.46M , beating expectations by +1.13%.
Earnings released on 7 May 2024
EPS came in at -$0.30 matching the estimated -$0.30, while revenue for the quarter reached $51.11M , beating expectations by +4.17%.
Earnings released on 27 Feb 2024
EPS came in at -$0.10 falling short of the estimated -$0.09 by -11.11%, while revenue for the quarter reached $62.21M , beating expectations by +2.74%.
Earnings released on 9 Nov 2023
EPS came in at -$0.28 falling short of the estimated -$0.26 by -7.69%, while revenue for the quarter reached $40.76M , missing expectations by -30.79%.
Earnings released on 8 Aug 2023
EPS came in at -$0.20 surpassing the estimated -$0.23 by +13.04%, while revenue for the quarter reached $41.95M , beating expectations by +2.70%.
Earnings released on 8 May 2023
EPS came in at -$0.23 matching the estimated -$0.23, while revenue for the quarter reached $42.20M , beating expectations by +7.53%.
Earnings released on 7 Mar 2023
EPS came in at -$0.08 surpassing the estimated -$0.13 by +38.46%, while revenue for the quarter reached $49.77M , beating expectations by +11.22%.
Earnings released on 8 Nov 2022
EPS came in at -$0.22 surpassing the estimated -$0.28 by +21.43%, while revenue for the quarter reached $33.06M , beating expectations by +9.71%.
Earnings released on 9 Aug 2022
EPS came in at -$0.23 falling short of the estimated -$0.21 by -9.52%, while revenue for the quarter reached $29.97M , beating expectations by +4.47%.
Earnings released on 5 May 2022
EPS came in at -$0.16 surpassing the estimated -$0.20 by +20.00%, while revenue for the quarter reached $29.05M , beating expectations by +11.58%.
Earnings released on 3 Mar 2022
EPS came in at -$0.12 falling short of the estimated -$0.01 by -2.30K%, while revenue for the quarter reached $33.44M , beating expectations by +3.35%.
Earnings released on 4 Nov 2021
EPS came in at -$0.12 matching the estimated -$0.12, while revenue for the quarter reached $21.62M , beating expectations by +2.95%.
Earnings released on 5 Aug 2021
EPS came in at -$0.10 surpassing the estimated -$0.12 by +16.67%, while revenue for the quarter reached $20.65M , meeting expectations.
Earnings released on 25 May 2021
EPS came in at -$0.07 surpassing the estimated -$0.08 by +12.50%, while revenue for the quarter reached $18.71M , beating expectations by +20.00%.
Earnings released on 26 Apr 2021
EPS came in at $0.05 , while revenue for the quarter reached $24.11M .
Earnings released on 30 Sept 2020
EPS came in at -$0.06 , while revenue for the quarter reached $14.27M .
TMCI Stock Performance
Access detailed TMCI performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.